Prevention and treatment of peritoneal dialysis-related peritonitis

doi:10.3877/cma.j.issn.2095-3216.2015.01.006

Abstract

Abstract:

Peritoneal dialysis-associated peritonitis (PDAP) is a serious complication in peritoneal dialysis patients; it is an important goal of each PD center to reduce the risk of peritoneal dialysis-associated infection. In case of peritoneal dialysis-associated infection, empirical treatment should be given as early as possible; in the meantime, samples with high quality should be collected for effective microbiological diagnosis and drug sensitivity test so as to ensure the accuracy and effectiveness of anti-infection treatment. Each PD center should actively carry out team continuous quality improvement (CQI) plan, including continuous monitoring of infection, analyzing of the root cause of infection, establishing a mechanism for comprehensive evaluation of the risk of peritonitis, focusing on strengthening active prevention concept, laying emphasis on prevention in high-risk populations such as the olders and diabetes patients from the start of peritoneal dialysis treatment, taking a particular focus on formal training and retrain of operation, actively preventing diarrhea/constipation, and enhancing the nursing care of tunnel and exit-site, in order to reduce the probability of occurrence of PDAP as much as possible.

Key words: Peritoneal dialysis, Peritoneal dialysis-associated peritonitis, Prevention, Trainning

Hongguang Zheng, Hui Qiu. Prevention and treatment of peritoneal dialysis-related peritonitis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(01): 22-28.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2015.01.006

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2015/V04/I01/22

References 42

[1]	邱辉，王薇，张德伟，等．持续性非卧床腹膜透析患者腹膜透析相关腹膜炎病因学及病原学分析[J]. 中国实用内科杂志，2013，33(6)：460-463.
[2]	Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J]. Kidney Int, 2008, 73(4): 391-398.
[3]	Lobo JV, Villar KR, de Andrade Junior MP, et al. Predictor factors of peritoneal dialysis-related peritonitis [J]. J Bras Nefrol, 2010, 32(2): 156-164.
[4]	Oygar DD, Yalin AS, Altiparmak MR, et al. Obligatory referral among other factors associated with peritonitis in peritoneal dialysis patients[J]. Nefrologia, 2011, 31(4): 435-440.
[5]	Sirivongs D, Pongskul C, Keobounma T, et al. Risk factors of first peritonitis episode in Thai CAPD patients[J]. J Med Assoc Thai, 2006，89(Suppl 2): S138-S145.
[6]	Han SH, Lee SC, Ahn SV.Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients[J]．Nephrol Dial Transplant，2007，22(9): 2653-2658.
[7]	Huang JW, Hung KY, Yen CJ, et al.Systemic lupus erythematosus and peritoneal dialysis: outcomes and infectious complications[J]．Perit Dial Int，2011, 21(2): 143-147.
[8]	Nessim SJ, Bargman JM, Austin PC，et al.Predictors of peritonitis in patients on peritoneal dialysis: results of a large，prospective Canadian database[J]．Clin J Am Soc Nephrol, 2009, 4(7): 1195-1200.
[9]	Han SH, Lee SC, Ahn SV，et al.Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients[J]．Nephrol Dial Transplant, 2007, 22(9): 2653-2658.
[10]	Piraino B, Bernardini J, Brown E, et al. ISPD: Reducing the risks of PD-related infections [J]. Perit Dial Int, 2011, 31(6): 614-630.
[11]	Li PKT, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations [J]. Perit Dial Int, 2010, 30(4): 393-423.
[12]	邱辉，洪敏，郑红光．直型与卷曲型腹膜透析导管相关并发症和导管生存率的meta分析[J]．中国血液净化，2014，13(10)：689-694.
[13]	周岩，李建东，俞雨生，等．直型与卷曲型鹅颈腹膜透析导管的临床应用[J]．肾脏病与透析肾移植杂志，2011，20(3)：240-243.
[14]	Lobo JV, Villar KR, de Andrade Junior MP，et al.Predictor factors of peritoneal dialysis-related peritonitis [J]．J Bras Nefrol，2010, 32(2): 156-164.
[15]	Duranay M, Kanbay M, Turgut F，et al.Comparison of incidence of peritonitis between peritoneal dialysis solution types [J]．Nephron Clin Pract, 2007, 106(1): c57-c60.
[16]	Alfa MJ, Degagne P, Olson N, et al. Improved detection of bacterial growth in continuous ambulatory peritoneal dialysis effluent by use of BacT/Alert FAN bottles [J]. J Clin Microbiol, 1997, 35(4): 862-866.
[17]	Sewell DL, Golper TA, Hulman PB, et al. Comparison of large volume culture to other methods for isolation of microorganisms from dialysate [J]. Perit Dial Int, 1990, 10(1): 49-52.
[18]	Lye WC, Wong PL, Leong SO, et al. Isolation of organisms in CAPD peritonitis: a comparison of two techniques [J]. Adv Perit Dial, 1994, 10(1): 166-168.
[19]	Chow KM, Chow VC, Szeto CC, et al. Continuous ambulatory peritoneal dialysis peritonitis: broth inoculation culture versus water lysis method [J]. Nephron Clin Pract, 2007, 105(3): c121-c125.
[20]	Azap OK, Timurkaynak F, Sezer S, et al. Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis [J]. Transplant Proc, 2006, 38(2): 411-412.
[21]	Zelenitsky S, Barns L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998 [J]. Am J Kidney Dis, 2000, 36(5): 1009-1013.
[22]	Choi P, Nemati E, Banerjee A, et al. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization [J]. Am J Kidney Dis, 2004, 43(1): 103-111.
[23]	Lui SL, Li FK, Lo CY, et al. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection [J]. Adv Perit Dial, 2000, 16(1): 195-197.
[24]	Mitra A, Teitelbaum I. Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines [J]. Adv Perit Dial, 2003, 19(1): 255-259.
[25]	Szeto CC, Chow KM, Wong TY, et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal [J]. J Am Soc Nephrol, 2002, 13(4): 1040-1045.
[26]	Szeto CC, Kwan BC, Chow KM, et al. Recurrent and relapsing peritonitis: causative organisms and response to treatment [J]. Am J Kidney Dis, 2009, 54(4): 702-710.
[27]	Troidle L, Gorban-Brennan N, Finkelstein FO. Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis [J]. Adv Perit Dial, 2005, 21(1): 98-101.
[28]	Strippoli GF, Tong A, Johnson D, et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004, 18(4): CD004679.
[29]	Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections [J]. Perit Dial Int, 2011, 31(6): 614-630.
[30]	Campbell DJ, Johnson DW, Mudge DW, et al. Prevention of peritoneal dialysis-related infections [J]. Nephrol Dial Transplant, 2014, 10(7): 1-12.
[31]	Walker A, Bannister K, George C, et al. KHA-CARI guideline: peritonitis treatment and prophylaxis [J]. Nephrology (Carlton), 2014, 19(2): 69-71.
[32]	Strippoli GFM, Tong A, Johnson D, et al. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004, 18(4): CD004680.
[33]	Hagen SM, Lafranca JA, Ijzermans JNM, et al. A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival [J]. Kidney Int, 2014, 85(4): 920-932.
[34]	Hall G, Bogan A, Dreis S, et al. New directions in peritoneal dialysis patient trainning [J]. Nephrol Nurs J, 2004, 31(2): 149-154, 159-163.
[35]	Gadola L, Poggi C, Poggio M, et al. Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients [J]. Perit Dial Int, 2013, 33(1): 38-45.
[36]	Bordin G, Casati M, Sicolo N, et al. Patient education in peritoneal dialysis: an observational study in Italy [J]. J Ren Care, 2007, 33(4): 165-171.
[37]	Russo R, Manili L, Tiraboschi G, et al. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int, 2006, 70(103): S127-S132.
[38]	Holloway M, Mujais S, Kandert M, et al. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates [J]. Perit Dial Int, 2001, 21(4): 401-404.
[39]	Bernardini J, Price V, Figueiredo A, et al. Peritoneal dialysis patient training [J]. Perit Dial Int, 2006, 26(6): 625-632.
[40]	Luzar M, Coles G, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis [J]. N Engl J Med, 1990, 322(8): 505-509.
[41]	Piraino B. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective [J]? Nephrol Dial Transplant, 2010, 25(2): 349-352.
[42]	Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis [J]. Nephrol Dial Transplant, 2010, 25(2): 587-592.

Please choose a citation manager

Content to export